Extract

To assess the 2 year survival of patients with Stage III unresectable non-small cell lung cancer receiving consolidation gemcitabine or gemcitabine plus docetaxel following concurrent chemotherapy and radiation.

Inclusion criteria

• non-small cell lung cancer

Country

• Argentina
• China
• Korea, Republic of
• United States

Links

• nct
• ictrp